OMD retains the China J&J account, although the results in Indonesia and Australia, which are handled by Universal McCann, and India, where MediaCom and Universal share the business, were unclear at Media's press time.
Aegis’ Carat, which was invited to join the pitch last month (Media, 7 May), misses out in Asia-Pacific.
The $3 billion review kicked off in April, after the healthcare giant's acquisition of Pfizer Consumer Healthcare in 2006.